M Macy's
Macy's earnings company data as of 4:49 AM ET 10/22
- 1 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q4 | 2 Dec | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 10 Sep | EPS | 0.35 | 0.62 | Beat +77.1% |
| Rev | — | $170.0M | — |
Insider trades
Open-market buys and sales by M's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $2.6M sold by 3 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Paul Griscom SVP and ControllerSale$258K 10,077 shares at $25.63 28% of stakeTraded Jun 25 Filed Jun 26
-
Danielle L. Kirgan EVP, Chief HR OfficerSale$2M 85,000 shares at $23.92 62% of stakeTraded Dec 11, 2025 Filed Dec 11, 2025
-
Olivier Bron CEO, Bloomingdale'sSale$300K 13,500 shares at $22.21 72% of stakeTraded Dec 8, 2025 Filed Dec 9, 2025
Also filed in the last 12 months, not counted as buying or selling: 21 sales to cover taxes, 20 option exercises, 6 share withholdings for taxes, and 4 stock grants.
SEC filings
Recent issuer filings from EDGAR, 11 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02,5.07 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.